Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
5164 | 1663 | 23.2 | 81% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
8 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1276458 |
98 | 3 | TRANSPLANTATION//TRANSPLANTATION PROCEEDINGS//SURGERY | 75394 |
93 | 2 | TRANSPLANTATION//TRANSPLANTATION PROCEEDINGS//KIDNEY TRANSPLANTATION | 26351 |
5164 | 1 | TACROLIMUS//FK506//TRANSPLANTATION PROCEEDINGS | 1663 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | TACROLIMUS | authKW | 1032699 | 24% | 14% | 407 |
2 | FK506 | authKW | 263409 | 8% | 11% | 128 |
3 | TRANSPLANTATION PROCEEDINGS | journal | 179451 | 37% | 2% | 623 |
4 | TRANSPLANTATION | WoSSC | 111364 | 54% | 1% | 891 |
5 | ACMIA | authKW | 106817 | 0% | 73% | 8 |
6 | MEIA | authKW | 76488 | 1% | 42% | 10 |
7 | FUJISAWA AMER | address | 74964 | 0% | 58% | 7 |
8 | THERAPEUTIC DRUG MONITORING | authKW | 56110 | 5% | 4% | 82 |
9 | ANTIBODY CONJUGATED MAGNETIC IMMUNOASSAY | authKW | 55080 | 0% | 100% | 3 |
10 | TACROLIMUS METABOLITES | authKW | 55080 | 0% | 100% | 3 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Transplantation | 111364 | 54% | 1% | 891 |
2 | Immunology | 18154 | 50% | 0% | 830 |
3 | Surgery | 16038 | 52% | 0% | 869 |
4 | Medical Laboratory Technology | 5454 | 10% | 0% | 161 |
5 | Pharmacology & Pharmacy | 2315 | 23% | 0% | 390 |
6 | Toxicology | 977 | 8% | 0% | 132 |
7 | Urology & Nephrology | 315 | 5% | 0% | 79 |
8 | Pediatrics | 37 | 3% | 0% | 45 |
9 | Gastroenterology & Hepatology | 9 | 2% | 0% | 26 |
10 | Cell & Tissue Engineering | 5 | 0% | 0% | 4 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | FUJISAWA AMER | 74964 | 0% | 58% | 7 |
2 | KLIN TRANSPLANTAT CHIRURG | 42682 | 1% | 23% | 10 |
3 | FUJISAWA AMER INC | 41308 | 0% | 75% | 3 |
4 | EXPLORAT FONT RENALES | 36720 | 0% | 100% | 2 |
5 | PHARMA TECHNOL S | 36720 | 0% | 100% | 2 |
6 | DRUG MODELING CONSULTING | 27537 | 0% | 50% | 3 |
7 | CHEM MEASUREMENT CALIBRAT | 24479 | 0% | 67% | 2 |
8 | 565 HOCHSTETTER HALL | 18360 | 0% | 100% | 1 |
9 | ABT NIEREN HOCHDRUCKKRANHEITEN | 18360 | 0% | 100% | 1 |
10 | ABT TRANSPLANT CHIRURG | 18360 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | TRANSPLANTATION PROCEEDINGS | 179451 | 37% | 2% | 623 |
2 | THERAPEUTIC DRUG MONITORING | 44298 | 6% | 3% | 95 |
3 | TRANSPLANTATION | 13326 | 7% | 1% | 116 |
4 | CLINICAL TRANSPLANTATION | 6006 | 2% | 1% | 35 |
5 | TRANSPLANT INTERNATIONAL | 5334 | 2% | 1% | 30 |
6 | JAPANESE JOURNAL OF TRANSPLANTATION | 4308 | 0% | 4% | 6 |
7 | PEDIATRIC TRANSPLANTATION | 3499 | 1% | 1% | 21 |
8 | CLINICAL PHARMACOKINETICS | 1968 | 1% | 1% | 16 |
9 | LIVER TRANSPLANTATION AND SURGERY | 864 | 0% | 2% | 3 |
10 | CLINICAL BIOCHEMISTRY | 780 | 1% | 0% | 15 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | TACROLIMUS | 1032699 | 24% | 14% | 407 | Search TACROLIMUS | Search TACROLIMUS |
2 | FK506 | 263409 | 8% | 11% | 128 | Search FK506 | Search FK506 |
3 | ACMIA | 106817 | 0% | 73% | 8 | Search ACMIA | Search ACMIA |
4 | MEIA | 76488 | 1% | 42% | 10 | Search MEIA | Search MEIA |
5 | THERAPEUTIC DRUG MONITORING | 56110 | 5% | 4% | 82 | Search THERAPEUTIC+DRUG+MONITORING | Search THERAPEUTIC+DRUG+MONITORING |
6 | ANTIBODY CONJUGATED MAGNETIC IMMUNOASSAY | 55080 | 0% | 100% | 3 | Search ANTIBODY+CONJUGATED+MAGNETIC+IMMUNOASSAY | Search ANTIBODY+CONJUGATED+MAGNETIC+IMMUNOASSAY |
7 | TACROLIMUS METABOLITES | 55080 | 0% | 100% | 3 | Search TACROLIMUS+METABOLITES | Search TACROLIMUS+METABOLITES |
8 | LIMITED SAMPLING STRATEGY | 40843 | 1% | 14% | 16 | Search LIMITED+SAMPLING+STRATEGY | Search LIMITED+SAMPLING+STRATEGY |
9 | 13 O DEMETHYL TACROLIMUS | 36720 | 0% | 100% | 2 | Search 13+O+DEMETHYL+TACROLIMUS | Search 13+O+DEMETHYL+TACROLIMUS |
10 | PROGRAF | 30593 | 0% | 33% | 5 | Search PROGRAF | Search PROGRAF |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | STAATZ, CE , TETT, SE , (2004) CLINICAL PHARMACOKINETICS AND PHARMACODYNAMICS OF TACROLIMUS IN SOLID ORGAN TRANSPLANTATION.CLINICAL PHARMACOKINETICS. VOL. 43. ISSUE 10. P. 623-653 | 158 | 59% | 289 |
2 | VENKATARAMANAN, R , SWAMINATHAN, A , PRASAD, T , JAIN, A , ZUCKERMAN, S , WARTY, V , MCMICHAEL, J , LEVER, J , BURCKART, G , STARZL, T , (1995) CLINICAL PHARMACOKINETICS OF TACROLIMUS.CLINICAL PHARMACOKINETICS. VOL. 29. ISSUE 6. P. 404-430 | 99 | 94% | 386 |
3 | PETERS, DH , FITTON, A , PLOSKER, GL , FAULDS, D , (1993) TACROLIMUS - A REVIEW OF ITS PHARMACOLOGY, AND THERAPEUTIC POTENTIAL IN HEPATIC AND RENAL-TRANSPLANTATION.DRUGS. VOL. 46. ISSUE 4. P. 746-794 | 162 | 57% | 255 |
4 | WALLEMACQ, PE , VERBEECK, RK , (2001) COMPARATIVE CLINICAL PHARMACOKINETICS OF TACROLIMUS IN PAEDIATRIC AND ADULT PATIENTS.CLINICAL PHARMACOKINETICS. VOL. 40. ISSUE 4. P. 283 -295 | 65 | 80% | 56 |
5 | BARRACLOUGH, KA , ISBEL, NM , KIRKPATRICK, CM , LEE, KJ , TAYLOR, PJ , JOHNSON, DW , CAMPBELL, SB , LEARY, DR , STAATZ, CE , (2011) EVALUATION OF LIMITED SAMPLING METHODS FOR ESTIMATION OF TACROLIMUS EXPOSURE IN ADULT KIDNEY TRANSPLANT RECIPIENTS.BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. VOL. 71. ISSUE 2. P. 207-223 | 47 | 77% | 12 |
6 | BROOKS, E , TETT, SE , ISBEL, NM , STAATZ, CE , (2016) POPULATION PHARMACOKINETIC MODELLING AND BAYESIAN ESTIMATION OF TACROLIMUS EXPOSURE: IS THIS CLINICALLY USEFUL FOR DOSAGE PREDICTION YET?.CLINICAL PHARMACOKINETICS. VOL. 55. ISSUE 11. P. 1295 -1335 | 58 | 58% | 0 |
7 | CHRISTIANS, U , JACOBSEN, W , BENET, LZ , LAMPEN, A , (2002) MECHANISMS OF CLINICALLY RELEVANT DRUG INTERACTIONS ASSOCIATED WITH TACROLIMUS.CLINICAL PHARMACOKINETICS. VOL. 41. ISSUE 11. P. 813-851 | 111 | 34% | 141 |
8 | WALLEMACQ, PE , REDING, R , (1993) FK506 (TACROLIMUS), A NOVEL IMMUNOSUPPRESSANT IN ORGAN-TRANSPLANTATION - CLINICAL, BIOMEDICAL, AND ANALYTICAL ASPECTS.CLINICAL CHEMISTRY. VOL. 39. ISSUE 11. P. 2219-2228 | 72 | 76% | 90 |
9 | HOOKS, MA , (1994) TACROLIMUS, A NEW IMMUNOSUPPRESSANT - A REVIEW OF THE LITERATURE.ANNALS OF PHARMACOTHERAPY. VOL. 28. ISSUE 4. P. 501-511 | 64 | 83% | 72 |
10 | BRUNET, M , (1997) TACROLIMUS (FK506). CLINICAL, PHARMACOLOGICAL AND ANALYTICAL ASPECTS.MEDICINA CLINICA. VOL. 109. ISSUE 3. P. 98-106 | 69 | 73% | 2 |
Classes with closest relation at Level 1 |